Concurrent Hepatoblastoma and Wilms Tumor Leading to Diagnosis of Beckwith-Wiedemann Syndrome

Revisiting the Threshold for Cancer Genetics Referral in Patients With Wilms Tumor

(2022) Joyce T. Turner et al.   JOURNAL OF CLINICAL ONCOLOGY

Doxorubicin in combination with cisplatin, 5‐flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study

(2021) Howard M. Katzenstein et al.   CANCER

Multi-locus imprinting disturbances of Beckwith-Wiedemann and Large offspring syndrome/Abnormal offspring syndrome: A brief review

(2021) Paula Magnelli Mangiavacchi et al.   THERIOGENOLOGY

Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study

(2020) Sümeyye Cöktü et al.   BRITISH JOURNAL OF CANCER

Simultaneous Presentation of Wilms’ Tumor and Contralateral Ganglioneuroma in a Child

(2018) Zuhal Bayramoglu et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement

(2018) Frédéric Brioude et al.   Nature Reviews Endocrinology

Pediatric Solid Tumors of Infancy: An Overview

(2018) Wendy Allen-Rhoades et al.   PEDIATRICS IN REVIEW

Simultaneous Presentation of Wilms Tumor and Immature Ovarian Teratoma in Beckwith-Wiedemann Syndrome

(2017) Jason C. White et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Assisted Reproductive Techniques and Risk of Beckwith-Wiedemann Syndrome

(2017) Alessandro Mussa et al.   PEDIATRICS

Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol

(2016) Alessandro Mussa et al.   JOURNAL OF PEDIATRICS

(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome: a paradigm for genomic medicine

(2015) A. Mussa et al.   CLINICAL GENETICS

Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

(2010) József Zsíros et al.   JOURNAL OF CLINICAL ONCOLOGY

Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

(2009) Giorgio Perilongo et al.   NEW ENGLAND JOURNAL OF MEDICINE